Edit Symbol List
Enter up to 25 symbols separated by commas or spaces in the text box below. These symbols will be available during your session for use on applicable pages.
Don't know the stock symbol? Use the symbol lookup tool.
Alphabetize the sort order of my symbols
ETFs with ABBV as a Top 10 Holding*
|Weighting||ETF Name (Symbol)||100-Day Price Change (%)|
|8.99%||First Trust IPOX-100 Index Fund (FPX)||+3.64 (8.57%)|
|4.94%||Merrill Lynch Pharmaceutical HOLDRS (PPH)||+7.11 (13.63%)|
|4.38%||Guggenheim Spin-Off ETF (CSD)||-0.02 (-0.04%)|
|3.64%||Select Sector SPDR Fund - Health Care (XLV)||+2.73 (4.92%)|
|3.61%||SPDR S&P Pharmaceuticals ETF (XPH)||+7.82 (8.94%)|
**Green highlights the top performing ETF by % change in the past 100 days.
Company Description (as filed with the SEC)
On January 1, 2013, AbbVie(1) became an independent company as a result of the distribution by Abbott Laboratories (Abbott) of 100 percent of the outstanding common stock of AbbVie to Abbott's shareholders. Each Abbott shareholder of record as of the close of business on December 12, 2012 (the Record Date) received one share of AbbVie common stock for each Abbott common share held as of the Record Date. AbbVie was incorporated in Delaware on April 10, 2012 to hold Abbott's former research-based pharmaceuticals business. AbbVie's common stock began trading "regular-way" under the ticker symbol "ABBV" on the New York Stock Exchange on January 2, 2013. Overview AbbVie is a global, research-based biopharmaceutical company. AbbVie develops and markets advanced therapies that address some of the world's most complex and serious diseases. ... More ...
|Annual EPS Est:||$3.14|
|Quarterly EPS Est:||0.68|